SyndicateRoom uses data analysis to build diverse portfolios through its Access EIS Fund, co-investing alongside vetted angel investors.
Portfolio
10
companies
MindSpire
MindSpire builds neurotechnology wearables for real-time stress relief and peak mental performance.
Noggin HQ
Noggin HQ builds financial technology to improve credit access for underserved UK consumers.
iCustoms
iCustoms provides artificial intelligence trade compliance and customs clearance solutions.
Finexos
Finexos provides a cloud-based credit and affordability risk analytics platform for lenders.
MyPocketSkill
MyPocketSkill operates a financial capability and earning platform for young people.
growyze
Stock management and loss prevention platform for the hospitality industry.
Lab 1
Lab 1 operates a contextual knowledge graph of data breaches to help organisations quantify supply chain cybersecurity risk.
.png)
Antiverse
Antiverse develops AI-designed therapeutic antibodies for challenging disease targets using computational platforms and in-house laboratories.
ThoughtRiver
ThoughtRiver delivers automated contract pre-screening software for legal teams.
Sorex Sensors
Sorex Sensors develops high-sensitivity MEMS mass sensors for industrial and consumer applications.
Tom Britton
Founding Partner
The pre-seed round was led by SFC Capital with participation from SyndicateRoom and Innovate UK.
"Our goal is to create a solution that performs just as well for executives managing stress and recovery as it does for individuals rebuilding from chronic conditions. It reflects our commitment to making nervous system care accessible, especially for those who need it most"
.png)
Oxford Capital led the pre-seed round to help the startup launch its first product.
"As two women from the North East, we’ve had to overcome significant challenges to get to this stage. But as a result, we’re extremely intentional in our approach. And we’re unwavering in our commitment to do right by people"
Fuel Ventures led the seed financing round to help the company expand its technology team and develop new offerings.
"Our goal at iCustoms is to make trading simple for all of us,"
The oversubscribed round was led by Growth Capital Ventures with participation from SyndicateRoom and existing backers.
"We are thrilled to continue receiving the backing of such seasoned investors. This marks a significant milestone for Finexos and is testament to the dedication of our entire team in propelling the company to this pivotal stage. We greatly look forward to strengthening existing partnerships and forging new connections as we work to empower financial institutions to make more informed credit decisions and drive improved outcomes for both lenders and borrowers."
The funding round was backed by angel networks, syndicate funds and high profile individual investors.
"At MyPocketSkill we are passionate about supporting young people to develop the skills to become employable and the financial habits to become financially capable, which often go hand-in-hand. Our goal is now to reach over a million young people in the next three years and this funding puts us well on target for that."
The London-based hospitality stock control platform has raised over £660k to expand its product capabilities.
"What growyze is offering may seem like a simple solution but behind the scenes, we quickly realised that Kati and the team are bringing the very latest workflow automation to an industry that thrives on really small margins…and every penny matters."
The financing round was backed by investors including MMC Ventures and SyndicateRoom.
"Lab 1 is the first cyber intelligence platform of its kind to contextualise the network effect of breaches"
The seed round was supported by a syndicate of investors including the Development Bank of Wales and the UKI2S Innovate Accelerator to fund platform development and laboratory expansion.
"Our investors recognise the potential of our AI-powered antibody drug discovery platform to provide a breakthrough in the industry. With our technology, it will be possible to develop drugs for difficult targets and ultimately reduce drug discovery timescales from years to weeks. In addition to platform development, the funding will enable us to invest in facilities and recruitment; we are grateful to our investors and Innovate UK for their continued support."
The Cambridge-founded legal tech company has secured £7.5m from Octopus Ventures and existing backers to scale its US presence and sales operations.
"To receive this investment in the current climate is testament to the relevance of ThoughtRiver’s technology, when across the globe, businesses are looking to do more with less."
The funding round was led by Cambridge Enterprise with backing from Cambridge Angels, SyndicateRoom and Camvision.
"The team has done a fantastic job so far and Mario will continue to work closely with Michael as we ramp up production and bring new products to market,"
